A Comparative Study between SmartArc, Tomotherapy and IMRT Techniques Applied to Pancreatic Cancer Treatment

2011 ◽  
Vol 81 (2) ◽  
pp. S836-S837
Author(s):  
M. Ashenafi ◽  
J. Peng
Keyword(s):  
Pancreatic Cancer ◽  
Comparative Study ◽  
Cancer Treatment

Targeting EGFR in Pancreatic Cancer Treatment

2012 ◽  
Vol 13 (6) ◽  
pp. 802-810 ◽  
Author(s):  
T. Troiani ◽  
E. Martinelli ◽  
A. Capasso ◽  
F. Morgillo ◽  
Michele Orditura ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Treatment

Bioinspired adhesive microneedle patch with gemcitabine encapsulation for pancreatic cancer treatment

2021 ◽  
pp. 133362
Author(s):  
Xiao Fu ◽  
Xiaoxuan Zhang ◽  
Danqing Huang ◽  
Liang Mao ◽  
Yudong Qiu ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Treatment ◽  
Microneedle Patch

Centralization of pancreatic cancer treatment within an integrated healthcare system improves overall survival

2021 ◽  
Author(s):  
Diana S. Hsu ◽  
Nikathan S. Kumar ◽  
Sidney T. Le ◽  
Alex L. Chang ◽  
George Kazantsev ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Overall Survival ◽  
Cancer Treatment ◽  
Healthcare System ◽  
Integrated Healthcare

scholarly journals CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment

Cell Reports ◽  
2021 ◽  
Vol 37 (9) ◽  
pp. 110060
Author(s):  
Jennifer E. Klomp ◽  
Ye S. Lee ◽  
Craig M. Goodwin ◽  
Björn Papke ◽  
Jeff A. Klomp ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Dna Damage ◽  
Cancer Treatment

scholarly journals Advanced pancreatic cancer: The standard of care and new opportunities

2018 ◽  
Author(s):  
Amrallah A. Mohammad
Keyword(s):  
Pancreatic Cancer ◽  
Mortality Rate ◽  
Cancer Treatment ◽  
Molecular Analysis ◽  
Therapeutic Approach ◽  
Locally Advanced ◽  
Advanced Pancreatic Cancer ◽  
Standard Of Care

Presentation of pancreatic cancer is localized, locally advanced or metastatic. With the later represented the main bulk (more than 80%). Despite the significant innovation in molecular analysis and therapeutic approach in many types of cancer in the last two decades, still the outcome of advanced pancreatic cancer is disappointing and the mortality rate approximately unchanged. In this mandated review we intended to highlight the standard of care and emerging agents for advanced pancreatic cancer treatment.

Sign in / Sign up

Export Citation Format

Share Document